Circulating Tumor Cell Dx Is Technology To Watch In 2009 – Cleveland Clinic

Use of circulating tumor cell assays to predict chemotherapy success will be the most significant medical innovation to break through in 2009, a panel of Cleveland Clinic physicians predicts